A small hormone study illustrates why weight change, blood markers and symptoms need separate comparisons.

A promising pilot study can guide the next research question without settling treatment choices.

STEP 9 offers a useful example of distinguishing pain relief from claims about joint repair.

A study with mostly women can be relevant to women without proving a women-specific effect.

NIST explains why a documented measurement chain matters more than a traceable sticker.

Traceability belongs to a measurement result and requires a supported chain of comparisons.

The SELECT trial shows how to read cardiovascular benefit using both event counts and study boundaries.

Clinical benefit is clearest when the outcome, comparison and population stay attached to the number.

A three-year liraglutide trial illustrates why duration and completeness of follow-up must be read together.

A long study provides valuable evidence, but missing follow-up still limits what it can establish.